| | Class 2 Device Recall BD FACSLyric |  |
| Date Initiated by Firm | November 01, 2024 |
| Date Posted | December 23, 2024 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0746-2025 |
| Recall Event ID |
95729 |
| 510(K)Number | K170974 K201814 |
| Product Classification |
Flow cytometric reagents and accessories. - Product Code OYE
|
| Product | Device Description:
FACSLyric 2L6C Instrument US, Catalog Number 662876, UDI 00382906628763
The K170974 clearance document describes the device as follows:
The BD FACSLyric" flow cytometer (3-1, 4-2, 4-2-2, and 4-3-3 optical
configurations) systems consist of a flow cytometer, sheath tank, waste tank, and a
computer workstation. System options include an automated FACS Universal Loader and
a barcode reader.
The BD FACSLyric Flow Cytometer includes the 488 nm laser and 640 nm laser as part
of four available manufactured instrument configurations.
BD FACSLyric Flow Cytometer, 3-1 configuration, 4-color/2-laser
BD FACSLyric Flow Cytometer, 4-2 configuration, 6-color/2-laser
BD FACSLyric Flow Cytometer, 4-2-2 configuration, 8-color/3-laser
BD FACSLyric Flow Cytometer, 4-3-3 configuration, 10-color/3-laser
The lower level configurations are upgradeable to higher level configurations by adding
filters, photomultiplier tubes (PMTs), and a laser. Only the 488 nm laser and 640 nm
lasers are utilized for cleared in vitro diagnostic (IVD) applications and only fluorescence
channels 1 (FL1) through FL6 are the subject of this 510(k) submission. Seven to tencolor immunophenotyping is for research use only (RUO).
All optical configurations of the FACSLyric share the same dimensions: 22.8 inches in
height by 24.93 inches in width by 22.8 inches in depth.
The K201814 clearance document describes the device as follows:
Refer to K170974 for detailed description and functioning of the BD FACSLyric flow cytometer.
The modified BD FACSLyric Flow Cytometer consists of the following components.
" FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2 ,4-3-3 and 4-3-5 optical configurations)
" FACSuite Clinical Software (version 1.4)
" Modified FACS Universal Loader: updated shaker and modification to the door lock and
sensor connections
" Modified CMS firmware
BD FACSLyric Flow Cytometer with the integrated BD FACSDuet Sample Preparation system
consists of all the above components as FACSLyric Flow Cytometer and additionally contain:
" BD FACSDuet Sample Preparation system physically and data integrated with the BD
FACSLyric Flow Cytometer
" FACSDuet fluidics that contain saline, deionized (DI) water and 10% bleach solution.
" Modified FACS Universal Loader: updated shaker, modification to the door lock and sensor connections, addition of stabilization bracket |
| Code Information |
Power supply part number 650781 with serial numbers beginning with V2309, V2318, and V2330 are impacted.
Catalog Number: 662876
UDI-DI code: 00382906628763
Instrument Serial Numbers / Power Supply Serial Numbers:
Z662876000065 V23300165
Z662876000044 V23090245
Z662876000045 V23090338
Z662876000048 V23180201
Z662876000047 V23180258
Z662876000051 V23180476
Z662876000050 V23180466
Z662876000049 V23180113
Z662876000052 V23180415
Z662876000053 V23180190
Z662876000056 V23300354
Z662876000055 V23300347
Z662876000057 V23300249
Z662876000059 V23300174
Z662876000061 V23300274
Z662876000062 V23300132
Z662876000060 V23300286
Z662876000063 V23300163
Z662876000066 V23300232
Z662876000054 V23300408
|
Recalling Firm/ Manufacturer |
Becton, Dickinson and Company, BD Bio Sciences 155 N Mccarthy Blvd Milpitas CA 95035-5102
|
Manufacturer Reason for Recall | On October 18, 2024, BD has identified through customer complaints and an increase in field failures / replacements of the power supply module (part number 650781, Power Module AC-DC 250W 12/24V M3S4S6) on BD FACSLyric flow cytometers, which has the potential for the instruments to fail to power on and/or stay on. The potential power supply failure on BD FACSLyric Flow Cytometer may lead to risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. The patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). In addition, patient specimen loss and/ or delay providing results of testing results. There may be additional risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. In addition, the patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). In the Notification Letter sent on November 20, 2024, customers are instructed to continue their normal operation of your BD FACSLyric Flow Cytometer according to the Instructions For Use after immediately inspecting inventory for the specific catalog and power supply serial numbers listed in the notification letter and follow the instructions listed under Actions for Clinical Users. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | On Nov 18, 2024, BD has identified through complaints an increase in field failures / replacements of the power supply module (part number 650781, Power Module AC-DC 250W 12/24V M3S4S6) on BD FACSLyric flow cytometers, which has the potential for the instruments to fail to power on and/or stay on. The potential power supply failure caused by BD FACSLyric Flow Cytometer may involve patient specimen loss and/ or delay to provide results of testing results. There may be additional risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. In addition, the patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). Customers are instructed to continue normal operation of your BD FACSLyric Flow Cytometer according to the Instructions For Use. Ensure the contents of this notification are read and understood. Immediately inspect your inventory for the specific catalog and power supply serial numbers listed above and follow the instructions listed under Actions for Clinical Users . Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted product, so that BD may acknowledge your receipt of this notification as per FDA requirement. |
| Quantity in Commerce | 20 power supplies |
| Distribution | Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia & Wisconsin. The countries of China, Costa Rica, Singapore, Thailand. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = OYE
|
|
|
|